Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000040227Phase 4Recruiting
Phase 4, randomised trial in endometritis comparing Dydrogesterone + doxycycline with Doxycycline alone (2 arms). Primary endpoint: Syndecan-1 (CD138) status. Started Jan 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000040227.